Advertisement

Topics

Oxford BioMedica Company Profile

06:02 EDT 23rd July 2018 | BioPortfolio

Oxford BioMedica advanced gene therapy techniques.

Location

Robert Robertson AvenueThe Oxford Science Park
Oxford
Oxfordshire
OX4 4 GA
United Kingdom

Contact

Phone: +44 1865 783 000
Fax: +44 1865 783 001
Email: p.nolan@oxfordbiomedica.co.uk


News Articles [316 Associated News Articles listed on BioPortfolio]

Oxford BioMedica set to earn $100 million in deal with Sanofi takeover target

UK gene cell therapy designer Oxford BioMedica’s shares jumped as much as 11.2% to 12.30 pence this…

Axovant buys rights for Oxford BioMedica’s Parkinson’s candidate

Biopharmaceutical firm Axovant Sciences has agreed exclusive worldwide rights for the development and commercialisation of gene therapy company Oxford BioMedica’s...Read More... The post Axovant buy...

Oxford BioMedica: Vector Value: An Interview with Nick Woolf, SVP Corporate Strategy

Fintan Walton talks to Nick Woolf, Senior Vice President, Corporate Strategy, Oxford BioMedica, about the company’s ongoing success as it moves toward its ultimate goal of becoming a fully integrate...

Oxford BioMedica secures £3m grant from Innovate UK

Innovate UK has awarded Oxford BioMedica a £3m grant to support the UK's efforts to produce viral vectors and ensure adequate supply to meet future demand.

Oxford BioMedica a secures £3m grant from Innovate UK

Oxford BioMedica has been awarded a £3 million grant by the UK's innovation agency, Innovate UK, to support the UK's efforts to produce viral vectors and ensure adequate supply to meet future demand.

Oxford BioMedica, Bioverativ sign $100M deal to develop gene therapy material

Bioverativ awarded a $100 million contract to the UK's Oxford BioMedica to develop lentiviral vectors for use in Bioverativ's -More- 

Oxford BioMedica, Bioverativ to Develop Lentiviral Vectors for Hemophilia Gene Therapy

Oxford BioMedica said today it will partner with Bioverativ to develop and manufacture lentiviral vectors designed to treat hemophilia, through a collaboration that could generate up to $105 million-p...

Oxford Biomedica announces placing to inject £20.5m for expansion

Oxford Biomedica intends to raise approximately £20.5m by way of a conditional placing of ordinary shares to raise money for expansion of bioprocessing facilities, the company said on Friday. The p.....

Drugs and Medications [0 Results]

None

Clinical Trials [85 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

Comparison of Oxford UKA and Sigma UKA With RSA.

Comparison of two unicompartmental knee arthroplasties (UKA), to see if Sigma UKA performs equally good as the Oxford UKA. The study focuses on how well the arthroplasty is fixated to the ...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

Companies [108 Associated Companies listed on BioPortfolio]

Oxford BioMedica

Oxford BioMedica advanced gene therapy techniques.

Oxford BioMedica plc

Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the...

BioMedica Inc.

Oxford BioMedica (LSE: OXB) is a biopharmaceutical company specialising in the development of novel gene-based therapeutics with a focus on the areas of oncology and neurotherapy. The Company was esta...

Boston Biomedica Incorporated

Boston Biomedica, Inc. is an infectious diseases management company providing products and services for the detection and treatment of infectious diseases (ID) such as AIDS, Lyme Disease, and Viral He...

Oxford Resource Partners, LP

Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fir...

More Information about "Oxford BioMedica" on BioPortfolio

We have published hundreds of Oxford BioMedica news stories on BioPortfolio along with dozens of Oxford BioMedica Clinical Trials and PubMed Articles about Oxford BioMedica for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford BioMedica Companies in our database. You can also find out about relevant Oxford BioMedica Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...


Corporate Database Quicklinks



Searches Linking to this Company Record